Eliquis Active substance: apixaban Common name: apixaban ATC code: B01AF02 Marketing authorisation holder: Bristol-Myers Squibb / Pfizer EEIG Status: Authorised Authorisation date: 2011-05-18 Therapeutic area: Arthroplasty Venous Thromboembolism Pharmacotherapeutic group: Antithrombotic agents Therapeutic indication For Eliquis 2.5 mg film-coated tablets: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention ... Eliquis 5mg Tablet is an anticoagulant used to prevent and treat blood clots, reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It also helps prevent clots in conditions like deep vein thrombosis and pulmonary embolism by inhibiting clot formation. Eliquis (Apixaban Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Find patient medical information for Eliquis (apixaban) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
